10,000+ stock pitches from top investors available on joinyellowbrick.com
BAKER BROS. ADVISORS LP 13F Holdings
Holdings from the most recent 13F from BAKER BROS. ADVISORS LP
Filed: 2023-11-14 (Q3 2023) | Holdings: 101 | Value: $17.4B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| SGEN - Seagen Inc. | 54.48% | $9.5B | |||||
| BGNE - BeiGene, Ltd. | 12.10% | $2.1B | +22.64% | -27.05% | -5.50% | ||
| INCY - Incyte Corporation | 12.05% | $2.1B | +19.51% | +8.32% | +39.36% | ||
| ACAD - ACADIA Pharmaceuticals Inc. | 5.15% | $893.3M | -6.91% | +8.68% | -27.62% | ||
| BMRN - BioMarin Pharmaceutical Inc. | 1.94% | $337.1M | -31.51% | +4.15% | -25.19% | ||
| MDGL - Madrigal Pharmaceuticals, Inc. | 1.30% | $225.6M | +75.92% | +42.02% | +84.43% | ||
| RYTM - Rhythm Pharmaceuticals, Inc. | Add 3% ($4.7M) | 0.89% | $153.7M | +88.36% | +55.01% | +72.70% | |
| ROIV - Roivant Sciences Ltd. | Add 26% ($28.6M) | 0.80% | $138.7M | +18.81% | +23.78% | +21.08% | |
| IMCR - Immunocore Holdings plc | 0.75% | $130.8M | -24.71% | +45.03% | -35.01% | ||
| N/A - Invitae Corporation | 0.75% | $130.4M | |||||
| AKRO - Akero Therapeutics, Inc. | 0.69% | $119.8M | +234.57% | +44.27% | +89.29% | ||
| ABCL - AbCellera Biologics Inc. | Add 26% ($19.8M) | 0.55% | $95.5M | -54.09% | +20.00% | -39.77% | |
| BCRX - BioCryst Pharmaceuticals, Inc. | 0.52% | $90.0M | +104.37% | +7.22% | +33.65% | ||
| REPL - Replimune Group, Inc. | 0.45% | $78.3M | -19.03% | -30.93% | -2.61% | ||
| TRDA - Entrada Therapeutics, Inc. | 0.44% | $76.9M | -55.00% | -11.07% | +5.68% | ||
| RVMD - Revolution Medicines, Inc. | 0.43% | $74.5M | +89.88% | +42.07% | +165.69% | ||
| ARGX - argenx SE | Reduce 46% $(63.4M) | 0.43% | $74.3M | +16.49% | -20.04% | +14.66% | |
| SWTX - SpringWorks Therapeutics, Inc. | 0.40% | $69.4M | +110.88% | +116.84% | +64.56% | ||
| KYMR - Kymera Therapeutics, Inc. | Add 9% ($5.2M) | 0.38% | $66.0M | +71.83% | +116.93% | +143.25% | |
| IMTX - Immatics N.V. | 0.38% | $65.3M | -44.26% | +18.82% | -15.51% | ||
| MRTX - Mirati Therapeutics, Inc. | 0.35% | $61.4M | |||||
| KNSA - Kiniksa Pharmaceuticals, Ltd. | 0.28% | $48.8M | +72.08% | +26.86% | +33.90% | ||
| RARE - Ultragenyx Pharmaceutical Inc. | Add 75% ($20.8M) | 0.28% | $48.7M | -11.22% | +20.69% | +16.75% | |
| DNLI - Denali Therapeutics Inc. | Add 57% ($17.3M) | 0.27% | $47.3M | -30.79% | -4.03% | +30.95% | |
| PRLD - Prelude Therapeutics Inc. | 0.18% | $31.3M | -72.32% | +8.75% | -67.50% | ||
| KOD - Kodiak Sciences Inc. | 0.18% | $31.2M | +82.80% | +191.40% | +197.31% | ||
| NRIX - Nurix Therapeutics, Inc. | 0.18% | $30.5M | +69.27% | +56.85% | +264.97% | ||
| BMEA - Biomea Fusion, Inc. | 0.17% | $29.0M | -83.65% | +96.94% | -25.88% | ||
| IDYA - IDEAYA Biosciences, Inc. | 0.17% | $28.7M | -33.17% | +56.05% | -10.48% | ||
| CERS - Cerus Corporation | Add 7% ($1.9M) | 0.16% | $27.9M | -27.01% | +37.36% | -1.15% | |
| AVTE - Aerovate Therapeutics, Inc. | 0.15% | $26.6M | +49.86% | -82.48% | |||
| IGMS - IGM Biosciences, Inc. | 0.15% | $26.4M | -73.71% | +218.84% | +96.07% | ||
| XENE - Xenon Pharmaceuticals Inc. | 0.15% | $25.7M | -2.76% | +64.11% | +34.24% | ||
| CABA - Cabaletta Bio, Inc. | 0.14% | $24.3M | -89.62% | +32.63% | -83.19% | ||
| GLUE - Monte Rosa Therapeutics, Inc. | Add 63% ($9.1M) | 0.14% | $23.5M | +18.75% | +57.10% | +119.89% | |
| DBVT - DBV Technologies S.A. | 0.11% | $19.9M | -3.35% | -0.98% | -65.86% | ||
| KRYS - Krystal Biotech, Inc. | 0.11% | $19.7M | +22.78% | +10.52% | +66.43% | ||
| VERV - Verve Therapeutics, Inc. | 0.11% | $18.8M | -59.55% | +20.73% | -56.45% | ||
| BCYC - Bicycle Therapeutics plc | 0.10% | $17.0M | -44.08% | +50.27% | +48.23% | ||
| IMVT - Immunovant, Inc. | New Purchase | 0.09% | $16.3M | -57.54% | +8.09% | -23.85% | |
| COGT - Cogent Biosciences, Inc. | New Purchase | 0.07% | $12.6M | -24.23% | +23.68% | +23.96% | |
| DAWN - Day One Biopharmaceuticals, Inc. | New Purchase | 0.07% | $12.3M | -47.36% | +26.73% | +9.82% | |
| PRME - Prime Medicine, Inc. | 0.06% | $9.8M | -83.14% | +11.43% | -52.21% | ||
| TSVT - 2seventy bio, Inc. | 0.06% | $9.8M | +153.07% | +54.39% | |||
| RLAY - Relay Therapeutics, Inc. | 0.06% | $9.8M | -63.50% | +29.81% | -37.90% | ||
| PACB - Pacific Biosciences of California, Inc. | 0.05% | $9.4M | -86.69% | -7.87% | -77.97% | ||
| INSM - Insmed Incorporated | New Purchase | 0.05% | $8.7M | +188.14% | +18.80% | +173.93% | |
| ADAP - Adaptimmune Therapeutics plc | New Purchase | 0.05% | $8.6M | -40.31% | +155.10% | +19.71% | |
| TNGX - Tango Therapeutics, Inc. | New Purchase | 0.05% | $8.4M | -71.43% | +52.12% | -50.45% | |
| HRTX - Heron Therapeutics, Inc. | New Purchase | 0.05% | $8.4M | +156.34% | +292.69% | +62.26% | |
| ANAB - AnaptysBio, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| KDNY - Chinook Therapeutics, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| DICE - DICE Therapeutics, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| IMGN - ImmunoGen, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| SPRY - ARS Pharmaceuticals, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| STOK - Stoke Therapeutics, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| SMMT - Summit Therapeutics Inc. | Reduce 100% | 0.00% | $0.00 | ||||